# A Study of the Safety of Atezolizumab in Participants With Locally Advanced or Metastatic Non Small Cell Lung Cancer in Argentina

> **NCT03321695** · — · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 44 (actual)

## Conditions studied

- Carcinoma, Non-small-cell Lung

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03321695
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-27
- **Primary completion:** 2019-03-02
- **Final completion:** 2019-03-02
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2023-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03321695

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03321695, "A Study of the Safety of Atezolizumab in Participants With Locally Advanced or Metastatic Non Small Cell Lung Cancer in Argentina". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03321695. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*